MAIA Biotechnology CEO Details Anticipated Clinical Milestones for Novel Cancer Immunotherapy in 2025 Letter to Shareholders ...

Multiple THIO trials planned in additional cancer indications ... for the treatment of NSCLC patients with telomerase-positive cancer cells. For more information, please visit www.maiabiotech.com.

Cell aging has always been an important topic in biological research, and telomere shortening is one of the key issues in ...

The interplay between aging and cellular senescence reveals insights into chronic inflammation and potential strategies for ...

Background and aims Human telomerase reverse transcriptase (hTERT) plays an important role in cancer invasion, but the relevant mechanism is not well known. This study aims to investigate the role and ...

Researchers are studying why the energy factories are moving between cells and whether the process can be harnessed to treat ...

Johns Hopkins Medicine scientists say they have found a pattern of so-called epigenetic "marks" in a transition state between ...

Scientists are looking for answers about how these confounding trips, known as metastases, occur throughout the human body ...

A new research paper was published in Oncotarget, Volume 16, on March 21, 2025, titled “NSD2-epigenomic reprogramming and ...

Scientists are looking for answers about how these confounding trips, known as metastases, occur throughout the human body Illustration of a human cancer cell Amber Dance, Knowable Magazine Back ...